Gabor Hutas, Ph.D.
Affiliations: | 2009 | Semmelweis Egyetem, Hungary |
Area:
ImmunologyGoogle:
"Gabor Hutas"Parents
Sign in to add mentorPeter Gergely | grad student | 2009 | Semmelweis Egyetem | |
(A CD44 ellenes monoklonalis antitest kezeles hatasmechanizmusa kiserletes artritiszben.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ho KA, Acar M, Puig A, et al. (2019) What do Australian patients with inflammatory arthritis value in treatment? A discrete choice experiment. Clinical Rheumatology |
Nagyeri G, Radacs M, Ghassemi-Nejad S, et al. (2011) TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin. The Journal of Biological Chemistry. 286: 23559-69 |
Hutas G. (2010) Golimumab as the first monthly subcutaneous fully human anti-TNF-alpha antibody in the treatment of inflammatory arthropathies. Immunotherapy. 2: 453-60 |
Hutas G. (2008) Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies. Current Opinion in Investigational Drugs (London, England : 2000). 9: 1206-15 |
Hutás G, Bajnok E, Gál I, et al. (2008) CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood. 112: 4999-5006 |
Hutas G. (2008) Golimumab, a fully human monoclonal antibody against TNFalpha. Current Opinion in Molecular Therapeutics. 10: 393-406 |
O'Neill SK, Cao Y, Hamel KM, et al. (2007) Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. Journal of Immunology (Baltimore, Md. : 1950). 179: 5109-16 |